Ecografia abdominală cu contrast (CEUS) este o metodă de examinare relativ nouă, care combină examinarea ecografică tradi ională cu injectarea unei cantită i foarte mici de substan ă de contrast într-o venă periferică (de obicei vena cubitală). Substan a de contrast folosită este compusă din microbule de gaz stabilizate într-o suspensie de fosfolipide. Dimensiunile microbulelor sunt foarte mici, cuprinse între 1-10 micrometri, fiind prea mari pentru a ieși din vasele de sânge, dar suficient de mici pentru a pătrunde în microcircula ia capilară, și pot fi folosite ca trasori vasculari. Astfel, este posibilă eviden ierea microvasculariza iei organelor parenchimatoase în diferite faze vasculare, imagini similare celor ob inute la examinarea CECT și CEMRI. Substan a de contrast se elimină prin plămâni în timpul expira iei și, din această cauză, principala contraindica ie pentru folosirea ei o reprezintă pacien ii cu insuficien ă respiratorie severă. De asemenea, substan a de contrast nu determină reac ii alergice, procentul de reac ii alergice raportate la numarul de cazuri fiind extrem de redus (0,001%). Cele mai importante avantaje ale metodei sunt: l poate fi folosită în siguran ă pentru pacien ii alergici la substan ele de contrast cu administrare intravenoasă folosite la CECT și CEMRI l poate fi folosită și la pacien ii la care substan a de contrast intravenoasă nu se poate administra din cauza bolii renale cronice. Ecografia abdominală cu contrast este folosită cel mai frecvent în practică pentru evaluarea forma iunilor tumorale hepatice, dar și pentru patologia tumorală pancreatică, renală, testiculară, precum și în bolile inflamatorii intestinale. Cuvinte cheie: ecografie cu contrast, microbule, microvasculariza ie, non-alergenic, tumori hepatice.
Contrast-enhanced ultrasound can be used to image blood perfusion in different organs.
Contrast-enhanced ultrasound is regarded as safe in adults, comparable to the safety of MRI contrast agents, and better than radiocontrast agents used in contrast CT scans. A true benefit is seen in patients with contraindications for CECT or CEMRI, such as renal failure or claustrophobia . (1) The more limited safety data in children suggests that such use is as safe as in the adult population. Also, there are limited data regarding the use of CEUS in pregnancy and breastfeeding . An informed consent must (2) be obtained before performing CEUS.
The microbubble contrast agents has the following general features: 
The most important pathology in which we can use CEUS is liver pathology, but is not the only one. CEUS is used more and more also in p a n c re a t i during the late phase with no wash out . The (6) specificity can be as high as 99% . 
Adenomas often needed guided biopsy for a definite diagnosis. In a Romanian (11, 12) multicentre study, CEUS had 60% sensitivity, 85,1% specificity and 83,9% accuracy for diagnosing ICC . (7, 13) 7. Liver metastases. The typical US appearance is of a "target" lesion that can be hyper-or hypo-echoic. ON CEUS most liver metastases are hypoenhancing in the arterial phase, sometimes with a rim e n h a n c e m e n t , b u t t h e y c a n b e hypervascular with hyperenhancing in the arterial phase, also. Characteristic for the majority of liver metastases is early and progressive wash-out, started at the end of the arterial phase . 
Hepatocellular carcinoma (HCC
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phase, hypoenhancement of the wall and septa can be seen . CEUS is helpful to find (6) avascular areas inside the abscess in order to guide percutaneous drainage . In a ( 7 , 1 4 ) Romanian multicentre study, CEUS had 76,9% sensitivity, 88,9% specificity,and 86,9% accuracy to diagnose liver abscesses . delineation of the tumor and the assessment of vascular invasion . By contrast, ( 2 0 ) neuroendocrine tumors have an intense enhancement in the arterial phase . For (22) both types of lesions, CEUS is useful for detecting liver metastases in the late phase ("wash-out" of liver lesions).
Cystic focal pancreatic lesions. CEUS
is useful for the differential diagnosis between pseudocysts, which are completely nonenhancing during CEUS, as opposed to cystic tumors, where the cystic wall, as well as the septa and protrusions will enhance after the contrast bolus . Several studies confirmed the value of CEUS for detecting pancreatic necrosis and for predicting the severity of AP, with sensitivity ranging from 82% to 90.3% and specificity from 89% to 98.8% . (24, 25) 
Kidney
Kidney CEUS ia a safe diagnostic method especially in patients with renal dysfunction . (7) 1. Solid renal tumors. It sometimes may be difficult to differentiate "real" renal tumors from so-called pseudotumors, and CEUS is considered highly effective for this indication .The enhancement pattern of (28) pseudotumors mirrors must be the same like that of the surrounding tissues in all phases.
Any other enhancing pattern should be considered suspicious for malignancy . (15, 28) The (17) identify more septa, characterize them as thicker and pick up solid components within cystic lesions at least as accurately as CT . 
Testis
In the case of testis pathology, CEUS is very useful for evaluating testicular torsion and inflammations (orchitis, epididymitis), including abscesses. In testicular tumors, CEUS is useful in the discrimination between cysts (no enhancement) and solid tumors, but there is no specific pattern in relation with the tumor type.
In testicular trauma the hematoma is anechoic on conventional US and with no enhancement on CEUS . (7, 26) 
Inflammatory bowel diseases
CEUS is used mainly for Crohn disease, in the differentiation between active and inactive disease and in the diagnosis of Crohn disease complications. Also, CEUS is useful for the differential diagnosis between inflammatory pseudo-tumors (intense enhancement within the lesion and in the peripheral tissue) and abscesses (peripheral enhancement without enhancement within the lesion). The usefulness and practical applicability of CEUS in ulcerative colitis is less defined so far . (7) CEUS is also useful for the diagnosis of acute 
